Speakers
Dr. Etsuro Mori is a board-certified neurologist with subspecialties in behavioral neurology and stroke. He received his M.D. from Kobe (1977). He completed his postgraduate medical education at Kobe University Hospital with training in neurology and earned Ph.D. from Institute of Medical Science, Kobe University Graduate School of Medicine (1982). After working in Hyogo Brain and Heart Center at Himeji, Scripps Clinic and Research Foundation in La Jolla, CA, USA, and Hyogo Institute for Aging Brain and Cognitive Disorders in Himeji, Japan, he became a chairman and professor of Department of Behavioral Neurology and Cognitive Neuroscience, Tohoku University Graduate School of Medicine in 2003. In 2017, he was elected as Professor Emeritus, Tohoku University, and was appointed professor of Department of Behavioral Neurology and Neuropsychiatry, United Graduate School, Osaka University. Dr. Mori has published more than 300 papers on aspects of stroke, behavioral neurology, dementia, and idiopathic normal pressure hydrocephalus in international peer-reviewed journals. With his colleagues, he discovered and conceptualized disproportionately enlarged subarachnoid hydrocephalus (DESH), as a neuroimaging hallmark of iNPH, and led multicenter studies of iNPH in Japan.
Etsuro Mori, MD, PhD
Professor, Department of Behavioral Neurology and Neuropsychiatry,
Osaka University
Professor Emeritus, Tohoku University
Geir Ringstad MD PhD is Consultant Neuroradiologist and Chair of the Neuroimaging Research Group at Oslo University Hospital in Norway, and is past president of the Norwegian Society of Neuroradiology. His main research focus has for the last 10 years been on cerebrospinal fluid flow and CSF related brain disorders. Together with neurosurgeon prof. Per Kristian Eide, he brought intrathecally enhanced MRI (gMRI) to the clinical field with their 2017 paper in Brain on gMRI in iNPH dementia. Ringstad and co-workers were the first to demonstrate that human CSF communicates with all brain regions and that sleep deprivation impairs brain molecular clearance. Their recent papers in Nature Communications and Brain are the first to show molecular efflux from CSF to human lymph-near dural tissue and skull bone marrow, respectively. Dr. Ringstad has been invited speaker on the current topic at several international meetings, lately at the Annual Meeting of the ASNR 2022 in New York and will also be speaker at this years` upcoming Annual Meeting of the ESNR in Lisbon and RSNA in Chicago.
Geir Ringstad, MD PhD
Department of Radiology, Oslo University Hospital, Oslo, Norway
Dr. Madoka Nakajima,M.D., Ph.D
Associate Professor, Department of Neurosurgery, Juntendo University Hospital
Shigeki Yamada is an assistant professor at the Department of Neurosurgery, Shiga University of Medical Science, and a researcher at the Numerical Fluid Dynamics Laboratory, Institute of Industrial Science, University of Tokyo.
Shigeki obtained a doctor's license in 1997 and belonged to the Department of Neurosurgery, Kyoto University. He studied the basics of Genetics, Statistics, 3D Imaging, and Computational Fluid Dynamics in the Ph.D. course at Kyoto University Graduate School from 2001 to 2005 (2 papers were published in Circulation and 4 in Stroke about genetics and statistics of intracranial aneurysm).
He specializes in neurosurgery, neuroimage, microvascular surgery, idiopathic normal pressure hydrocephalus (iNPH), and V-P shunting.
He had studied iNPH from Prof. Masatsune Ishikawa at the Rakuwakai Otowa hospital since 2013.
He has been published in more than 30 journal papers on hydrocephalus and cerebrospinal fluid since 2015.
He has been collaborating with Fujifilm Co., Ltd. on application development of 3D volume analyzer SYNAPSE 3D since 2017.
His research themes in 2022 are 3D fluid analysis of the brain and 3D gait movement analysis of healthy elderly and iNPH patients.
Shigeki Yamada
Assistant professor (hospital lecturer), Department of Neurosurgery, Shiga University of Medical Science, Shiga, Japan
Researcher, Interfaculty Initiative in Information Studies / Institute of Industrial Science, The University of Tokyo, Tokyo, Japan
Dr. Graff-Radford is the David Eisenberg Professor at Mayo Clinic. He completed a Neurology Residency at the University of Colorado Health Science Center in Denver, a fellowship in Behavioral Neurology with Dr. Damasio in Iowa where he stayed on the faculty for 7 years. He has been at Mayo Clinic Jacksonville for 32 years and was promoted to full Professor at the Mayo College of Medicine in 1994. He served as Chair of the Department of Neurology for 10 years until 2004. His research is in Alzheimer disease, Frontotemporal Demential, Lewy Body Disease and Normal Pressure Hydrocephalus. Dr. Graff-Radford has been NIH funded since 1991 and has published over 660 peer review papers
Neill R. Graff-Radford
MBBCh, FRCP (London)
Marita Andersson Grönlund is a professor in Ophthalmology. She has extensive experience of leading positions as a pediatric ophthalmologist, lecturer, and researcher at Sahlgrenska University Hospital in Gothenburg, Sweden. She is now also programme director for the Medical Programme at Örebro University, Sweden.
Marita Andersson Grönlund is heading a research group called “Acquired and genetic influence of eye growth and visual function”. This project pertains to a large proportion of children and young adults growing up in the world today. We have an increasing proportion of infants suffering from pre- and perinatal complications, resulting in growth restriction and congenital defects, affecting brain and visual system development. Since brain growth and the visual system are not fully developed at birth, preventive measures and treatment should be able to have positive effects even later in childhood. The functioning and the morphology of the eye and the visual system can be measured by relatively simple methods, and objective measurements can be carried out of the optic nerve, the thickness of the retina and retinal vessels. A successful completion of this project will not only lead to a better understanding of pathophysiology and prognosis, but also have an impact on prevention, diagnostics, and treatment.
Marita Andersson Grönlund, MD, PhD
Professor in Ophthalmology
Graduated from the Charles University Medical School in Hradec Kralove, Czech Republic, in 1992. Employed as radiologist at the Department of Diagnostic Radiology, University Hospital in Hradec Kralove, Czechia between 1992 - 2007 and 2010 - 2016, respectively (Head of the MRI unit). Between 2007 and 2010, working as Consultant Radiologist at Dumfries and Galloway Royal Infirmary, Dumfries, United Kingdom. Employed at the Department of Imaging and Functional Medicine, University Hospital of Umeå, Sweden, as Consultant Neuroradiologist since 2016 until now. Professor of Radiology at Charles University in Prague since November 2008. Professional profile focused on neuroradiology and MR imaging. First author or co-author of 15 medical monographies and textbooks, 105 scientific articles and more than 270 oral papers.
Jan Zizka, M.D., Ph.D.
Professor of Radiology
Dept. of Imaging and Functional Medicine
University Hospital of Umeå
907 37 Umeå
Sweden
Dr. Ville Leinonen is a Professor of Neurosurgery at University of Eastern Finland (UEF) and Kuopio University Hospital in Kuopio Finland. He obtained his MD (2002) and PhD (2004) from University of Kuopio. He received Duodecim Young Investigator Award in 2015 and elected to professor of Neurosurgery in University of Oulu in 2017. In 2020 he was invited to his current position in UEF. He has over 130 peer reviewed original publications with H-index 31 (Scopus).
Since 2010 he has been a director of Kuopio NPH Patient, Family and Tissue Registry with on-going recruitment of so far over 1100 patients with possible idiopathic normal pressure hydrocephalus (iNPH) focusing on pathophysiology and prognosis of iNPH and early Alzheimer’s disease. The collection contains e.g., brain biopsy, blood and CSF samples integrated with life-long follow-up.
Ville Leinonen
University of Eastern Finland
Kuopio University Hospital
Graduated University of Århus, Denmark in 1973. Specialist in Neurology 1980.
PhD Thesis 1982: "Cerebrospinal Fluid Proteins in Degenerative Neurological.
Disorders". Dept. of Neurology, Gothenburg University Sweden.
2000 Professor of Neurology, Gothenburg University, Sweden.
Chairperson at the Institution of Clinical Neuroscience, Faculty of Medicine, Gothenburg University, 1997-2005.
Head of Division of Clinical Neuroscience, Sahlgrenska University Hospital, 1996-97.
Professor Emeritus 2014 -.
Co-editor for Acta Neurologica Scandinavica 2007 - 2021.
President of ”Hydrocephalus2006”, International Meeting in Gothenburg.
President of the International Society of Hydrocephalus and CSF disorders (ISHCSF) 2008 -2010.
President of Nordic Hydrocephalus Academy 2006 -2010.
Sixteen PhD students. Around 160 peer reviewed articles published.
Carsten Illum Wikkelsø
Dr. Kerstin Andrén completed her Neurology Residency at Sahlgrenska University Hospital in Gothenburg in 2016, followed by work in the Hydrocephalus team at Sahlgrenska, with special interest in NPH and movement disorders. She is currently working as a general neurologist. In 2020 she completed a doctorate thesis on the natural course and long-term prognosis in iNPH, raising the awareness of the importance of early shunt surgery to diminish morbidity and mortality in iNPH.
Kerstin Andrén, MD, PhD
Hydrocephalus Unit, Department of Clinical Neuroscience,
Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg
Neurology Clinic, Angered Local Hospital, Gothenburg
Nathalie Jurisch-Yaksi is trained as a molecular and cell biologist. Her research program aims at understanding molecular and cellular mechanisms underlying the development, physiology and diseases of the brain. Her laboratory focuses mainly on the function of cilia, cerebrospinal fluid flow and glia biology. To this end, she uses a multidisciplinary approach combining state-of-the-art cellular and molecular biology, genetics, microscopy, fluid dynamics, neural imaging, behavioral assays and quantitative data analysis. She mainly employ zebrafish due to its transparent body and brain that are amenable to optical imaging and genetic manipulations. Prior to leading her own team, she has worked on transcriptional regulation and paracrine signaling involved in cell survival (PhD, DKFZ, Heidelberg, Germany), high-throughput drug-screens and chemical biology to interfere with cellular differentiation (postdoc, Harvard Medical School, USA), and cellular mechanisms of neurodegenerative diseases (postdoc, VIB-KU Leuven, Belgium). Since 2015, she has been leading her own team, first as a senior researcher within the Yaksi Lab (Kavli Institute for Systems Neuroscience, NTNU, Norway), and since 2019, as an independent Group Leader at NTNU’s department of Clinical and Molecular Medicine.
Nathalie Jurisch-Yaksi, PhD
Department of Clinical and Molecular Medicine
The Faculty of Medicine and Health Science, NTNU
Erling Skjalgsons gate 1
Laboratoriesenteret 5. floor
7491 Trondheim
Norway